摘要
目的研制尼莫地平固体脂质纳米粒,并考察其理化性质及体外透皮特性。方法采用熔融超声-低温固化法制备尼莫地平固体脂质纳米粒,考察其形态、粒径、粒度分布、Zeta电位等理化性质,以RP-HPLC测定药物的包封率和载药量,以改良的Franz扩散装置研究其体外释药和透皮扩散特性。结果优化条件下制备的尼莫地平固体脂质纳米粒均匀圆整,平均粒径为(104.47±3.98)nm,跨距为(0.96±0.04),包封率为(95.53±1.15)%,载药量为(9.22±0.12)%,Zeta电位为-(34.3±5.1)mV;体外药物呈缓释释放,符合Higuchi动力学模型:Q=0.1156t1/2-0.1373(r2=0.9905);体外透皮特性优于氮酮、油酸和丁香油对尼莫地平的促透作用。结论尼莫地平固体脂质纳米粒处方和工艺合理可靠,经皮渗透特性较佳,作为药物微载体可用于多种经皮给药系统的设计。
Abstract
OBJECTIVE To prepare nimodipine-loaded solid lipid nanoparticles(NIM-SLN) and investigate their physico-chemical properties and percutaneous permeability through excised SD rat skin in vitro.METHODS NIM-SLN were prepared using the hot dispersion-cool solidification method.The morphology,mean diameter,size distribution and Zeta potential of NIM-SLN were used to evaluate the influence of different formulation and preparation factors.The encapsulation efficiency(EE) and drug loading of NIM-SLN were determined by RP-HPLC.The release and permeate rate of NIM from NIM-SLN were detected by modified Franz diffusion cells method.RESULTS NIM-SLN prepared by the optimal formula and technology were spherical in shape,the mean diameter of NIM-SLN was(104.47±3.98)nm,the span was(0.96±0.04),the EE of NIM was(95.53±1.15)%,the drug loading was(9.22±0.12)%,and Zeta potential was-(34.3±5.1)mV.NIM-SLN exhibited good controlled release properties in vitro and the release rule was discvibed by Higuchi equation:Q=0.115 6t1/2-0.137 3(r2=0.990 5).NIM-SLN significantly enhanced the transdermal flux of NIM,compared with azone,oleic acid or clove oil alone.CONCLUSION NIM-SLN that exhibited good controlled release properties and stable percutaneous permeability in vitro were reasonable in formula,reliable in technology,and satisfied the demands of transdermal drug delivery system.
关键词
尼莫地平 /
固体脂质纳米粒 /
透皮特性
{{custom_keyword}} /
Key words
nimodipine /
solid lipid nanoparticles /
percutaneous permeability
{{custom_keyword}} /
王文刚;杨莉;王睿;付桂英;刘泽源;赵志刚.
尼莫地平固体脂质纳米粒的制备及其体外透皮特性研究[J]. 中国药学杂志, 2008, 43(08): 598-605
WNG Wen-gng;YNG Li;WNG Rui;FU Gui-ying;LIU Ze-yun;ZHO Zhi-gng.
Study on Preparation and in Vitro Percutaneous Permeability of Solid Lipid Nanoparticles Loaded with Nimodipine [J]. Chinese Pharmaceutical Journal, 2008, 43(08): 598-605
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] MULLER R H，RADTKE M，WISSING S A. Solid lipid nanoparticles(SLN) and nanostructured lipid carriers(NLC) in cosmeticand dermatological preparations[J] .Adv Drug Deliv Rev，2002，54(Suppl 1)：131-155.
[2] HU F Q，HONG Y，YUAN H. Preparation and characterization of solid lipid nanoparticles containing peptide[J] . Int J Pharm，2004，273(1-2)：29-35.
[3] LI J，DONG A J. Function of nanoparticles in transdermal and transmucosal drug delivery systems[J] .Chin J Chin Mater Med(中国中药杂志)，2004，29(3)：193-196.
[4] SOUTO E B，WISSING S A，BARBOSA C M，et al. Evaluation of the physical stability of SLN and NLC before and after incorporation into hydrogel formulations[J] .Eur J Pharm Biopharm，2004，58(1)：83-90.
[5] WISSING S A，LIPPACHER A，MULLER R H. Investigations on the occlusive properties of solid lipid nanoparticles(SLN)[J] . J Cosmet Sci，2001，52(5)：313-323.
[6] CHEN S，ZHENG J M. The observation on in vitro permeation and irritation of nimodipine patches[J] .J Shenyang Pharm Univ(沈阳药科大学学报)，2000，17(2)：84-86.
[7] KRISHNAIAH Y S, BHASKAR P.Studies on the transdermal delivery of nimodipine from a menthol-based TTS in human volunteers[J] .Curr Drug Deliv，2004，1(2)：93-102.
[8] CHEN G L，LI W Z，ZHOU Y，et al. Effect of compound penetration enhancers on permeability of nimodipine through rat skin[J] . Chin J Pharm(中国医药工业杂志)，1998，29(7)： 308-310.
[9] ZHOU J P，ZHANG J S，QI P. Study on penetration enhancers for nimodipine[J] . J Chin Pharm Univ(中国药科大学学报)，1994，25(3)：149-152.
[10] ZHOU J P，ZHONG M，HUANG J H. Study on transdermal therapeutic system for nimodipine[J] . J Chin Pharm Univ(中国药科大学学报)，2000，31(5)：348-351.
[11] MULLER R H，MADER K，GOHLA S. Solid lipid nanoparticles(SLN) for controlled drug delivery-a review of the state of the art[J] . Eur J Pharm Biopharm，2000，50(1)：161-177.
[12] SCHWARZ C，MEHNERT W. Solid lipid nanoparticles(SLN)for controlled drug delivery.Ⅱ.Drug incorporation and physic ochemical characterization[J] . J Microencapsulation，1999，16(2)：205-213.
[13] MEI Z，CHEN H，WENG T，et al. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide[J] .Eur J Pharm Biopharm，2003，56(2)：189-196.
(收稿日期：2007-12-15)（上接第593页）
[2] JI Y，LI J，YANG P. Effects of fruits of Hovenia dulcis Thumb on acute alcohol toxicity in mice[J] . J Chin Med Mater(中药材)，2001，24(2)：126-128.
[3] YE L P，ZHANG H，LIU X L. A morphological study of protective effect of Hovenia dulcis Thunb extract on hepatic fibrosis[J] . J Wuhan Univ（Med Edi）(武汉大学学报：医学版)，2005，26(3)：293-296.
[4] CHEN Q. Methodology on Pharmacological Research of Traditional Chinese Medicine (中药药理研究方法学)[M] . Beijing： People’s Medical Publishing House，1993：31.
[5] LIN G M，ZHAO H Y，FAN W J，et al . Effects of accumulation of lactic acid in atlanto-axial joint on abilities of learning and memory in senile mice[J] . J Jilin Univ（Med Edi）(吉林大学学报：医学版)，2006，32(6)：968-970.
[6] ZHANG Z H，CHEN X H，ZHANG L P，et al. Antiaging effects of beta-carotene from dunaliella saline on fruit flies and rats[J] . Chin Pharmacol Bull (中国药理学通报)，2006，22(11)：1324-1328.
[7] ZHANG Z M，GE B，XU A X，et al. Antisenile effect of polysaccharides from Fructus ligustri lucidi[J] . Chin J Pharmacol Toxical(中国药理学与毒理学杂志)，2006，20(2)：108～111.
[8] FLORA S J. Role of free radical and antioxidants in the health and disease[J] . Cell Mol Bio(Noisy-le-drand)，2007，15；53(1)：1-2.
[9] DAS R，PONNAPPAN S，PONNUAPPAN U. Redox regulation of the proteasome in T lymphocytes during aging[J] . Free Radic Biol Med，2007，42(4)：541-551.
[10] MEHMET G，BAHA O，HILMI D. Protective effects of vitamins C and E against endometrial damage and oxidative stress in fluoride intoxication[J] . Clin Exp Pharmacol Physiol，2007，34：467-474.
[11] WEI H，LI L，SONG Q，et al. Behavioural study of the D-galactose induced aging model in C57BL/6J mice[J] . Behav Brain Res，2005，157(2)：245-251.
[12] XU S Y，BIAN R L，CHEN X．Pharmacology Experiment Methodology(药理实验方法学)[M] //3rd ed. Beijing： People’s Medical Publishing House，2002：1465-1466.
[13] SHA M，DING L S. Chemical study on the seeds of Hovenia acerba L indl L[J] . J Chin Pharm Univ(中国药科大学学报)，2001，32(6)：418-420.
[14] WANG K J，CHEN L Z，LI N et al. Antioxidant and radical-scavenging activity of flavonoids from solidago Canadensis[J] . Chin Pharm J(中国药学杂志)，2006，41(7)：493-497.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
